Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 368703, 10 pages
http://dx.doi.org/10.1155/2014/368703
Review Article

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors

1Hanbang Body-Fluid Research Center and College of Oriental Medicine, Wonkwang University, 460 Iksandae-ro, Iksan 570-749, Republic of Korea
2Department of Internal Medicine, Wonkwang University School of Medicine & Hospital, 895 Muwang-ro, Iksan 570-711, Republic of Korea

Received 20 June 2014; Accepted 10 July 2014; Published 21 July 2014

Academic Editor: Dae Gill Kang

Copyright © 2014 Na-Hyung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [31 citations]

The following is the list of published articles that have cited the current article.

  • Emanuel Monteiro Candeias, Ana Isabel Duarte, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Catarina Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, and Paula Isabel Moreira, “Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.,” World journal of diabetes, vol. 6, no. 6, pp. 807–27, 2015. View at Publisher · View at Google Scholar
  • Leo Pruimboom, and Karin de Punder, “The opioid effects of gluten exorphins: asymptomatic celiac disease,” Journal of Health, Population and Nutrition, vol. 33, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yoshinobu Nakamaru, Fumihiko Akahoshi, Hiroaki Iijima, Noriko Hisanaga, and Toshiyuki Kume, “Tissue distribution of teneligliptin in rats and comparisons with data reported for other dipeptidyl peptidase-4 inhibitors,” Biopharmaceutics & Drug Disposition, vol. 37, no. 3, pp. 142–155, 2016. View at Publisher · View at Google Scholar
  • V. Darsalia, M. Larsson, G. Lietzau, D. Nathanson, T. Nyström, T. Klein, and C. Patrone, “Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor,” Diabetes, Obesity and Metabolism, vol. 18, no. 5, pp. 537–541, 2016. View at Publisher · View at Google Scholar
  • Dong-Sung Lee, Eun-Sol Lee, Md. Morshedul Alam, Jun-Hyeog Jang, Ho-Sub Lee, Hyuncheol Oh, Youn-Chul Kim, Zahid Manzoor, Young-Sang Koh, Dae-Gil Kang, and Dae Ho Lee, “Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate,” Metabolism, vol. 65, no. 2, pp. 89–101, 2016. View at Publisher · View at Google Scholar
  • Bengür Taşkıran, Bahattin Erdoğan, Canan Solak Şişman, and Güven Barış Cansu, “Bullous pemphigoid induced by vildagliptin,” Turkish Journal of Endocrinology and Metabolism, vol. 20, no. 4, pp. 140–143, 2016. View at Publisher · View at Google Scholar
  • Hsin-Ying Lu, Chun-Yao Huang, Chun-Ming Shih, Yi-Wen Lin, Chein-Sung Tsai, Feng-Yen Lin, and Chun-Che Shih, “A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms,” Journal of Vascular Surgery, 2016. View at Publisher · View at Google Scholar
  • Anneleen Mortier, Mieke Metzemaekers, Jo Van Damme, and Paul Proost, “Regulation of chemokine activity - A focus on the role of dipeptidyl peptidase IV/CD26,” Frontiers in Immunology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • M. Nauck, “Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors,” Diabetes, Obesity and Metabolism, vol. 18, no. 3, pp. 203–216, 2016. View at Publisher · View at Google Scholar
  • Kentaro Tsuboi, Hiroki Mizukami, Wataru Inaba, Masayuki Baba, and Soroku Yagihashi, “The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes,” Journal of Neurochemistry, vol. 136, no. 4, pp. 859–870, 2016. View at Publisher · View at Google Scholar
  • Dae-Gil Kang, Eun-Sol Lee, Dong-Sung Lee, Prakash Raj Pandeya, Youn-Chul Kim, Ho-Sub Lee, Byung-Chul Oh, and Dae Ho Lee, “Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters,” Korean Journal of Physiology and Pharmacology, vol. 21, no. 5, pp. 519–529, 2017. View at Publisher · View at Google Scholar
  • Pradip D. Patil, Umesh B. Mahajan, Kalpesh R. Patil, Sandip Chaudhari, Chandragouda R. Patil, Yogeeta O. Agrawal, Shreesh Ojha, and Sameer N. Goyal, “Past and current perspective on new therapeutic targets for Type-II diabetes,” Drug Design, Development and Therapy, vol. 11, pp. 1567–1583, 2017. View at Publisher · View at Google Scholar
  • Umadevi V. Wesley, and Robert J. Dempsey, “Chemokines and Proteolysis: Implications for Stem Cell Dynamics in Ischemic Stroke,” Cellular and Molecular Approaches to Regeneration and Repair, pp. 409–425, 2017. View at Publisher · View at Google Scholar
  • Masanori Hirose, Hiroyuki Takano, Hiroshi Hasegawa, Hiroyuki Tadokoro, Naoko Hashimoto, Genzo Takemura, and Yoshio Kobayashi, “The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure,” Journal of Pharmacological Sciences, 2017. View at Publisher · View at Google Scholar
  • Dirk von Lewinski, Ewald Kolesnik, Markus Wallner, Michael Resl, and Harald Sourij, “New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data,” BioMed Research International, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Biplab Giri, Mrinmoy Sarkar, and Sananda Dey, “Double Edge Effect Of Dpp4 Inhibitor Sitagliptin, A Type-2 Anti-Diabetic Drug, On Inflammation, Injury And Cancer,” Journal of Stem cell & Regenerative Biology, vol. 3, no. 1, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Nádia Duarte, Inês Coelho, Denys Holovanchuk, Joana Inês Almeida, Carlos Penha-Gonçalves, and Maria Paula Macedo, “Dipeptidyl Peptidase-4 Is a Pro-Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells,” Hepatology Communications, vol. 2, no. 9, pp. 1080–1094, 2018. View at Publisher · View at Google Scholar
  • Chun-Ming Shih, Chun-Yao Huang, Chien-Yu Huang, Kuo-Hsien Wang, Po-Li Wei, Yu-Jia Chang, Tsorng-Harn Fong, Jun-Liang Pan, and Ai-Wei Lee, “A dipeptidyl peptidase-4 inhibitor promotes wound healing in normoglycemic mice by modulating keratinocyte activity,” Experimental Dermatology, 2018. View at Publisher · View at Google Scholar
  • Samah S. Abbas, Hesham M. Mahmoud, Mona F. Schaalan, and Hanan S. El-Abhar, “Involvement of brain natriuretic peptide signaling pathway in the cardioprotective action of sitagliptin,” Pharmacological Reports, vol. 70, no. 4, pp. 720–729, 2018. View at Publisher · View at Google Scholar
  • Eugene A. Zubkov, Yana A. Zorkina, Elena V. Orshanskaya, Nadezhda N. Khlebnikova, Natalia A. Krupina, and Vladimir P. Chekhonin, “Changes in Gene Expression Profiles in Adult Rat Brain Structures after Neonatal Action of Dipeptidyl Peptidase-IV Inhibitors,” Neuropsychobiology, vol. 76, no. 2, pp. 89–99, 2018. View at Publisher · View at Google Scholar
  • Katarina Tomovic, Jelena Lazarevic, Gordana Kocic, Marina Deljanin-Ilic, Marko Anderluh, and Andrija Smelcerovic, “Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection,” Medicinal Research Reviews, 2018. View at Publisher · View at Google Scholar
  • Joelle de Melo Turnes, Taysa Bervian Bassani, Leonardo C. Souza, and Maria A. B. F. Vital, “Ineffectiveness of saxagliptin as a neuroprotective drug in 6-OHDA-lesioned rats,” Journal of Pharmacy and Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Milton Packer, “Worsening Heart Failure During the Use of DPP-4 Inhibitors,” JACC: Heart Failure, 2018. View at Publisher · View at Google Scholar
  • Wafaa A. Hewedy, “Linagliptin attenuates chronic post-ischemia pain: possible anti-inflammatory and anti-oxidant mechanisms,” European Journal of Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Markus Wallner, Deborah M. Eaton, Dirk von Lewinski, and Harald Sourij, “Revisiting the Diabetes-Heart Failure Connection,” Current Diabetes Reports, vol. 18, no. 12, 2018. View at Publisher · View at Google Scholar
  • Nada M. Kamel, Mai A. Abd El Fattah, Hanan S. El-Abhar, and Dalaal M. Abdallah, “Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways,” European Journal of Pharmacology, pp. 172620, 2019. View at Publisher · View at Google Scholar
  • E. V. Biryukova, “Clinical aspects and prospects of using DPP-4 inhibitors,” Medical Council, no. 4, pp. 24–29, 2019. View at Publisher · View at Google Scholar
  • Francesca Fiory, Giuseppe Perruolo, Ilaria Cimmino, Serena Cabaro, Francesca Chiara Pignalosa, Claudia Miele, Francesco Beguinot, Pietro Formisano, and Francesco Oriente, “The Relevance of Insulin Action in the Dopaminergic System,” Frontiers in Neuroscience, vol. 13, 2019. View at Publisher · View at Google Scholar
  • Ahmed M. Elmansi, Mohamed E. Awad, Nada H. Eisa, Dmitry Kondrikov, Khaled A. Hussein, Alexandra Aguilar-Pérez, Samuel Herberg, Sudharsan Periyasamy-Thandavan, Sadanand Fulzele, Mark W. Hamrick, Meghan E. McGee-Lawrence, Carlos M. Isales, Brian F. Volkman, and William D. Hill, “What doesn’t kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands,” Pharmacology & Therapeutics, 2019. View at Publisher · View at Google Scholar
  • Tae Hun Kim, Kiyoung Lee, Ie Byung Park, Cheol Soo Choi, Tae Hoon Ahn, and Dae Ho Lee, “The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 156, pp. 107832, 2019. View at Publisher · View at Google Scholar
  • Takamasa Iwakura, Zhibo Zhao, Julian A Marschner, Satish Kumar Devarapu, Hideo Yasuda, and Hans Joachim Anders, “Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration,” Nephrology Dialysis Transplantation, 2019. View at Publisher · View at Google Scholar